Connect with us

Technology

Tucuvi joins the Microsoft Pegasus Program to scale clinically governed AI Care Management across health systems

Published

on

Tucuvi brings a differentiated clinical approach to conversational AI within the Microsoft Pegasus Program, extending voice AI beyond administrative interactions into clinically governed care management.

BOSTON, Oct. 15, 2026 /PRNewswire/ — Tucuvi, an AI care management company, today announced it is joining the Microsoft for Startups Pegasus Program, which connects companies to Microsoft’s enterprise customer ecosystem and go-to-market channels.

For Tucuvi, the selection comes at a pivotal moment as the company scales its platform across health systems. Through Pegasus, Tucuvi will be able to bring its clinically-governed approach to AI care management to more organizations, helping them move beyond point solutions and deploy patient-facing AI across both administrative and clinical workflows on a single platform.

Health systems and life sciences companies can contract Tucuvi directly through Microsoft Marketplace or apply that spend against the Microsoft Azure commitment they have already made to Microsoft, turning a new vendor evaluation into a purchase against budget that is already allocated, through a procurement path their organization has already approved.

The Challenge

Health systems evaluating patient-facing AI increasingly need one platform that can support both patient access, such as scheduling, navigation and referral routing, and clinical enablement, like care-gap closure, medication adherence, transitions of care, monitoring and follow-up.

These are fundamentally different problems. In access, success means getting patients to the right service. In clinical care, AI must reliably follow protocols, capture clinically relevant information, and escalate the right cases to clinicians.

Tucuvi was built from the clinical side and expanded into access. Today, more than 80 health settings run 50+ workflow types on the platform.

LOLA®, clinical voice AI, and the platform behind it

Tucuvi Health Manager is Tucuvi’s AI care management platform. At its core is LOLA®, a clinical voice AI agent that holds inbound and outbound phone conversations with patients in natural language. LOLA follows configurable clinical and administrative protocols, captures structured information, and escalates cases when human intervention is required. The platform is omnichannel, extending the same workflows to text when needed.

LOLA® integrates with Microsoft Foundry as the platform layer for deploying and monitoring the models behind LOLA’s conversational capabilities in addition to Azure Speech for the voice layer of patient conversations.

Around LOLA®, care teams can configure protocols, manage escalations, coordinate workflows, and integrate with existing EHRs, CRMs and call center systems.

The platform also provides visibility into program performance including reach, engagement, escalations and workflow outcomes so teams can monitor and adjust programs while they are live.

Health systems and payers run LOLA across workflows including:

Post-discharge follow-up and Transitional Care Management (TCM)Chronic Care Management (CCM) and monitoring check-insCare-gap closure and quality outreach, including medication adherencePharmacy operations, such as prescription refillsPatient access workflows, such as scheduling

Clinical governance and safety

Clinical governance is built into the platform. Healthcare organizations can use evidence-based protocols or configure their own, define escalation criteria and workflow actions, while care teams retain oversight of patient interactions and clinical decisions.

Tucuvi’s technology is developed to medical-device safety standards and is certified as Class IIb Software as a Medical Device in the European Union, a level of clinical validation that remains uncommon among patient-facing voice AI platforms.

“Health systems tell us they want one platform across access and clinical care, and that the clinical side is where the requirements get strict,” said María González Manso, CEO and co-founder of Tucuvi. “What they ask us is not whether the agent sounds natural. It is who defines the protocol, what happens when a patient says something that needs a clinician, and whether the same thing happens on every call. Our model was proven in clinical workflows first, across more than 80 health settings, and that is the part that does not transfer easily from a customer service platform. The Pegasus Program lets us bring it to more health systems, faster.”

“We welcome Tucuvi to the Microsoft for Startups Pegasus Program. This initiative gives select startups access to Microsoft Azure’s cutting-edge AI models, enterprise-grade security and privacy, and unique go-to-market support to accelerate growth. Through Pegasus, startups like Tucuvi can build fast, scale smart, and sell more by tapping into the full power of Azure and the Microsoft ecosystem,” said Tom Davis, General Manager, Microsoft for Startups.

About Tucuvi

Tucuvi is the AI Care Management company. Its platform combines LOLA®, a clinical voice AI agent that holds inbound and outbound conversations with patients, with Tucuvi Health Manager, the care management layer where healthcare organizations configure clinical protocols, manage escalations and coordinate care workflows with clinical oversight.

Tucuvi’s model is proven across more than 80 health organizations and over 50 clinical workflows, spanning patient access, care transitions, chronic disease management, medication management and screenings. The platform is omnichannel and integrates with existing EHRs, CRMs and call center systems. Tucuvi’s technology is developed to medical-device safety standards and is classified as Class IIb Software as a Medical Device in the European Union.

Contact usExplore Success Stories

Marketing & Comms
Tucuvi
marketing@tucuvi.com

This release was issued through WebWire®. For more information, visit http://www.webwire.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/tucuvi-joins-the-microsoft-pegasus-program-to-scale-clinically-governed-ai-care-management-across-health-systems-302910378.html

SOURCE Tucuvi

Continue Reading

Technology

ASSA ABLOY sells PKI business unit to Vista Equity Partners

Published

on

By

STOCKHOLM, Oct. 16, 2026 /PRNewswire/ — ASSA ABLOY has signed an agreement to sell HID’s PKI business unit to Vista Equity Partners (“Vista”).

The PKI business unit (Public Key Infrastructure) provides digital trust, identity, authentication, encryption, and certificate management solutions. The business unit includes PKI SaaS – IdenTrust and HydrantID – credential management, and ZeroSSL.

“I find it very satisfying that with Vista, the PKI business unit and its employees and customers gain a committed long-term investor, creating new opportunities for the future and I wish them every success,” says Nico Delvaux, President and CEO of ASSA ABLOY.

“Our PKI team has built a strong business with a strong customer base, and Vista has the expertise to take it forward as the market evolves,” says Björn Lidefelt, EVP and Head of HID. “We are pleased with this outcome for our customers, our employees, and for HID.”

The divested business had sales in 2025 of MUSD 58 (approx. MSEK 570) with a strong operating margin.

The divestiture is subject to customary closing conditions and is expected to close during the fourth quarter of 2026.

For more information, please contact: 
Nico Delvaux, President and CEO, tel. no: +46 8 506 485 82
Erik Pieder, CFO and Executive Vice President, tel. no: +46 8 506 485 72
Björn Tibell, Head of Investor Relations, tel. no: +46 70 275 67 68, e-mail: bjorn.tibell@assaabloy.com

About ASSA ABLOY
ASSA ABLOY is the global leader in access solutions. Every day we help people feel safe, secure and experience a more open world. We operate worldwide with 64,000 employees and sales of SEK 152 billion, with leading positions in areas such as efficient door openings, trusted identities and entrance automation. Our innovations enable safe, secure and convenient access to physical and digital places.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/assa-abloy/r/assa-abloy-sells-pki-business-unit-to-vista-equity-partners,c4410007

The following files are available for download:

View original content:https://www.prnewswire.co.uk/news-releases/assa-abloy-sells-pki-business-unit-to-vista-equity-partners-302911635.html

Continue Reading

Technology

QBTS Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against D-Wave Quantum Inc.

Published

on

By

SAN DIEGO, Oct. 16, 2026 /PRNewswire/ — Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons who purchased or otherwise acquired D-Wave (NYSE: QBTS) securities between February 26, 2026 and August 25, 2026, inclusive (the “Class Period”). D-Wave is a company engaged in quantum computing.

The complaint alleges that D-Wave overstated its business and financial prospects.

The complaint alleges that D-Wave overstated its business and financial prospects.

Investors who purchased D-Wave Quantum Inc. securities during the Class Period and suffered significant losses should contact Robbins LLP before December 15, 2026 for information about the lawsuit.

Why Was D-Wave Sued?

According to the complaint, during the Class Period, defendants failed to disclose that:

(i) defendants materially overstated D-Wave’s business and financial prospects;
(ii) the foregoing was reasonably likely to negatively impact the Company’s business and reputation; and
(iii) as a result, defendants’ public statements were materially false and misleading at all relevant times.

Why Did D-Wave Stock Drop?

According to the complaint, the truth started to emerge on August 6, 2026, when D-Wave announced its financial results for the second quarter of 2026. Among other things, D-Wave reported revenue of just $3.08 million, compared to $3.1 million for the same period in the prior year, falling short of analyst expectations ranging from $4.03 million to $4.08 million. On this news, D-Wave’s stock price declined $1.99 per share, or 9.28%, to close at $19.41 per share on August 6, 2026.

Then, on August 25, 2026, D-Wave issued a press release “announc[ing] that John Markovich is retiring and thus resigning from his position as Chief Financial Officer effective September 2, 2026.” On this news, D-Wave’s stock price fell $1.84 per share, or 9.51%, closing at $17.51 per share on August 26, 2026.

What Can D-Wave Shareholders Do Now?

Investors who purchased D-Wave Quantum Inc. securities during the Class Period may be eligible to serve as lead plaintiff. The lead plaintiff is a court-appointed investor who represents the interests of all class members throughout the litigation. Stockholders who wish to seek appointment as lead plaintiff should contact Robbins LLP before the December 15, 2026 deadline for information about the appointment process.

Shareholders do not need to serve as lead plaintiff to share in any potential recovery. Investors who do not seek appointment may remain absent class members.

Does It Cost Anything to Participate?

No. Robbins LLP represents investors on a contingency fee basis, with no upfront or out-of-pocket fees or expenses.

Contact Robbins LLP

Investors seeking additional information about the D-Wave Quantum Inc. securities class action may contact Robbins LLP by submitting an inquiry, emailing attorney Aaron Dumas, Jr., or calling (800) 350-6003.

Why Robbins LLP?

A recognized leader in shareholder rights litigation, Robbins LLP represents investors in securities fraud and shareholder derivative litigation. We have helped restore more than $2 billion in value to shareholders and secured some of the largest recoveries in shareholder derivative litigation history. 

“Companies have an obligation to provide investors with complete and accurate information so that markets can function fairly and efficiently,” said Brian J. Robbins, Founding Partner of Robbins LLP.

To be notified if a class action against D-Wave Quantum Inc. settles, or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

View original content to download multimedia:https://www.prnewswire.com/news-releases/qbts-stockholder-notice-robbins-llp-reminds-investors-of-the-class-action-lawsuit-against-d-wave-quantum-inc-302911530.html

SOURCE Robbins LLP

Continue Reading

Technology

BUUU Group Limited Announces 10-for-1 Forward Share Split

Published

on

By

SINGAPORE, Oct. 16, 2026 /PRNewswire/ — BUUU Group Limited (Nasdaq: BUUU) (“BUUU” or the “Company”) today announced that its board of directors has approved a ten-for-one (10-for-1) forward split of the Company’s ordinary shares, to be effected by subdividing each of the Company’s issued and unissued Class A ordinary shares and Class B ordinary shares into ten shares of the same class (the “Share Subdivision”). The Share Subdivision is intended to make the Company’s Class A ordinary shares more accessible to a broader base of investors and to enhance their trading liquidity. Subject to processing by Nasdaq, the Class A ordinary shares are expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market at market open on October 26, 2026, under the Company’s existing symbol “BUUU.”

The Share Subdivision follows BUUU’s completion on September 15, 2026 of its acquisition of a 60% equity interest in Brightray Science Inc., through which the Company has established industrialized AI data center delivery as its core growth business.

Details of the Share Subdivision

Key date. The Class A ordinary shares are expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market at market open on October 26, 2026.

Ratio and mechanics. As a result of the Share Subdivision, each issued Class A ordinary share and each issued Class B ordinary share will be automatically subdivided into ten shares of the same class. As a result, each shareholder will hold ten shares of the relevant class for every share held immediately before the Share Subdivision (equivalent to nine additional shares for each share held). The Class A ordinary shares will continue to trade on the Nasdaq Capital Market under the symbol “BUUU.” The new CUSIP number of the Class A ordinary shares following the Share Subdivision will be G1739L110.

Authorized and outstanding shares. In connection with the Share Subdivision, the maximum number of shares the Company is authorized to issue will increase proportionately from 500,000,000 shares of no par value, divided into 250,000,000 Class A ordinary shares and 250,000,000 Class B ordinary shares, to 5,000,000,000 shares of no par value, divided into 2,500,000,000 Class A ordinary shares and 2,500,000,000 Class B ordinary shares.

Rights and ownership unchanged. The rights and restrictions attaching to each class of shares will remain unchanged, including the voting rights of one vote per Class A ordinary share and twenty votes per Class B ordinary share, and all shares of each class resulting from the Share Subdivision will rank pari passu in all respects with each other. The Share Subdivision will not change any shareholder’s percentage ownership interest or voting power in the Company. No fractional shares will result from the Share Subdivision.

No action required unless you hold physical certificates. No action is required by shareholders. Shareholders who hold Class A ordinary shares through a bank, broker or other nominee will have their positions automatically adjusted to reflect the Share Subdivision, subject to their nominee’s particular processes. The Company’s transfer agent, VStock Transfer, LLC (“VStock”), will update the holdings of registered shareholders in book-entry form. Registered shareholders holding share certificates will be asked to deliver a letter of transmittal to VStock to surrender their certificates to VStock in exchange for the right to receive post-Share Subdivision ordinary shares in electronic, book-entry form.

Outstanding securities. Proportionate adjustments will be made, to the extent provided by their respective terms, to the number of Class A ordinary shares issuable upon the exercise, conversion or settlement of, and to the exercise price or other per-share terms of, the Company’s outstanding warrants and other securities exercisable for, convertible into or settleable in Class A ordinary shares.

Approval. The Share Subdivision was approved by the Company’s board of directors on September 28, 2026.

The Company will furnish a copy of this press release to the U.S. Securities and Exchange Commission (the “SEC”) on Form 6-K.

About BUUU Group Limited

BUUU Group Limited (Nasdaq: BUUU) has established industrialized AI data center delivery as its core growth business, operated through Brightray Science Inc., in which BUUU acquired a controlling interest in September 2026. BUUU also provides meetings, incentives, conferences and exhibitions (MICE) solutions, including event management and stage production, for public institutions, agencies, real estate companies and established brands.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, Section 21E of the U.S. Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “may,” “will,” “would,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” and similar expressions. Forward-looking statements include statements regarding the expected timing and effectiveness of the Share Subdivision, including the date on which the Class A ordinary shares are expected to begin trading on a split-adjusted basis; the intended effects of the Share Subdivision, including on the accessibility and trading liquidity of the Class A ordinary shares; and the Company’s business strategy and prospects. Such statements are based on current expectations and assumptions and involve risks and uncertainties, many of which are beyond the control of BUUU, that could cause actual results to differ materially from those contained in the forward-looking statements. These risks and uncertainties include, but are not limited to: delays in, or the failure to complete, the steps required to implement the Share Subdivision, including registration of the amendment to the Company’s memorandum and articles of association in the British Virgin Islands and processing by Nasdaq, The Depository Trust Company, the Company’s transfer agent and brokers; the possibility that the Share Subdivision does not achieve its intended effects, including any improvement in trading liquidity or broadening of the Company’s investor base; the market price and trading volume of the Class A ordinary shares following the Share Subdivision, which may not adjust proportionately to the Share Subdivision, and the possibility of increased volatility; the effect of a lower per-share trading price on the Company’s continued compliance with Nasdaq listing requirements, including the minimum bid price requirement; the integration of Brightray into BUUU; competition in the data center industry; demand for AI computing infrastructure; changes in laws and regulations affecting the data center and AI computing industries, including trade and export control measures; and other risks described in BUUU’s filings with the SEC, including its most recent annual report on Form 20-F. Forward-looking statements speak only as of the date of this press release, and BUUU undertakes no obligation to update any forward-looking statement, except as required by applicable law.

 

View original content:https://www.prnewswire.com/news-releases/buuu-group-limited-announces-10-for-1-forward-share-split-302911448.html

SOURCE BUUU Group Limited

Continue Reading

Trending